GLUCOCORTICOID-RESISTANT POLYMYALGIA RHEUMATICA: CLINICAL CHARACTERIZATION AND TOCILIZUMAB THERAPY

被引：1
|
作者：
Mori, S. [1 ]
Koga, Y. [2 ]
机构：
[1] NHO Kumamoto Saishunsou Natl Hosp, Rheumatol, Kohshi, Japan
[2] NHO Kumamoto Saishunsou Natl Hosp, Radiol, Kohshi, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.3434
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0596
引用
收藏
页码：1002 / 1003
页数：2
相关论文
共 50 条
  • [1] Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
    Shunsuke Mori
    Yukinori Koga
    Clinical Rheumatology, 2016, 35 : 1367 - 1375
  • [2] Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy
    Mori, Shunsuke
    Koga, Yukinori
    CLINICAL RHEUMATOLOGY, 2016, 35 (05) : 1367 - 1375
  • [3] What is behind the elevated neutrophil to lymphocyte ratio in glucocorticoid-resistant polymyalgia rheumatica?
    Ito, Hiroshi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (09) : 1217 - 1217
  • [4] Analysis of musculoskeletal ultrasound findings and cytokines/growth factors in glucocorticoid-resistant polymyalgia rheumatica
    Origuchi, Tomoki
    Umeda, Masataka
    Fukui, Shoichi
    Furukawa, Kaori
    Shimizu, Toshimasa
    Sumiyoshi, Remi
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Iwamoto, Naoki
    Tamai, Mami
    Arima, Kazuhiko
    Kawakami, Atsushi
    IMMUNOLOGICAL MEDICINE, 2024,
  • [5] Effect of Tocilizumab on Disease Activity in Patients with Active Polymyalgia Rheumatica on Glucocorticoid Therapy: A Randomized Clinical Trial
    Devauchelle, Valerie
    Alegria, Guillermo Carvajal
    Dernis, Emmanuelle
    Richez, Christophe
    Truchetet, Marie
    Wendling, Daniel
    Toussirot, Eric
    Perdriger, Aleth
    Gottenberg, Jacques-Eric
    Felten, Renaud
    Fautrel, Bruno
    Chiche, Laurent
    Hilliquin, Pascal
    Le Henaff, Catherine
    Dervieux, Benjamin
    Direz, Guillaume
    Chary-Valckenaere, Isabelle
    Cornec, Divi
    Guellec, Dewi
    Marhadour, Thierry
    Nowak, Emmanule
    Saraux, Alain
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2196 - 2198
  • [6] Tocilizumab for polymyalgia rheumatica
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2022, 4 (04): : E250 - E250
  • [7] Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy A Randomized Clinical Trial
    Devauchelle-Pensec, Valerie
    Carvajal-Alegria, Guillermo
    Dernis, Emmanuelle
    Richez, Christophe
    Truchetet, Marie-Elise
    Wendling, Daniel
    Toussirot, Eric
    Perdriger, Aleth
    Gottenberg, Jacques-Eric
    Felten, Renaud
    Fautrel, Bruno Jean
    Chiche, Laurent
    Hilliquin, Pascal
    Le Henaff, Catherine
    Dervieux, Benjamin
    Direz, Guillaume
    Chary-Valckenaere, Isabelle
    Cornec, Divi
    Guellec, Dewi
    Marhadour, Thierry
    Nowak, Emmanuel
    Saraux, Alain
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (11): : 1053 - 1062
  • [8] Tocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica
    Hagihara, Keisuke
    Kawase, Ichiro
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (05) : 1075 - 1076
  • [9] TOWARD SAFER GLUCOCORTICOID THERAPY OF POLYMYALGIA RHEUMATICA
    Pan, X.
    Hou, Q.
    Xu, J.
    Ma, Y.
    Li, J.
    Li, M.
    Su, J.
    Shi, X.
    Bracken, W.
    Katz, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1004 - 1004
  • [10] In glucocorticoid-dependent polymyalgia rheumatica, tocilizumab improved a composite clinical outcome at 24 wk
    Pisetsky, David S.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (01) : JC5 - JC5
12345